Patents by Inventor Isabelle Pelisson

Isabelle Pelisson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8877968
    Abstract: Melanocortin receptor modulators, processes for preparing them and use thereof in human medicine and cosmetics are described. Melanocortin receptor modulators corresponding to formula (I): compositions containing them, processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: November 4, 2014
    Assignee: Galderma Research & Development
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Isabelle Pelisson, Pascal Collette, Samuel Tabet, Guillaume Lafitte
  • Publication number: 20120282314
    Abstract: Depigmenting compositions having improved effectiveness in the dermatological or cosmetic treatment of pigmentation contain, in a physiologically acceptable medium, at least one compound selected from among rucinol and salts thereof, and at least one retinoid; such compositions are also useful in the prevention and/or dermatological treatment of skin hyperpigmentation, and also for the cosmetic treatment of photoinduced or chronological aging of the skin or of the skin appendages.
    Type: Application
    Filed: July 17, 2012
    Publication date: November 8, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Isabelle PELISSON, Itaru SUZIKI
  • Publication number: 20110275657
    Abstract: Melanocortin receptor modulators, processes for preparing them and use thereof in human medicine and cosmetics are described. Melanocortin receptor modulators corresponding to formula (I): compositions containing them, processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 10, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Isabelle Pelisson, Pascal Collette, Samuel Tabet, Guillaume Lafitte
  • Publication number: 20110274727
    Abstract: Depigmenting topical compositions and their uses are described. In particular, the described compositions can provide improved effectiveness in the dermatological treatment of pigmentation, without disadvantages experienced with other known compositions. The described topical compositions can comprise, in a physiologically acceptable medium, from 3% to 10% of rucinol or one of its salts. Also described, are methods of use treating pigmentation disorders of the skin with the described compositions.
    Type: Application
    Filed: October 28, 2009
    Publication date: November 10, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Philippe Andres, Isabelle Pelisson
  • Publication number: 20110166113
    Abstract: Dermatological medicament compositions contain a combination of hydroquinone, fluocinolone acetonide and tretinoin and are useful for the treatment of the hyperpigmentation of pathological scars, namely, hypertrophic scars and keloidal scars.
    Type: Application
    Filed: March 14, 2011
    Publication date: July 7, 2011
    Applicant: Galderma S.A.
    Inventors: Isabelle PELISSON, André Jomard
  • Publication number: 20100160401
    Abstract: The tyrosinase inhibiting compounds of the following general formula formulated into pharmaceutical or cosmetic compositions, are useful for the treatment or prevention of pigmentary disorders, or for preventing and/or treating signs of skin aging, and/or for body or hair hygiene.
    Type: Application
    Filed: December 4, 2009
    Publication date: June 24, 2010
    Inventors: Jean-Guy BOITEAU, Isabelle Pelisson, Itaru Suzuki, Branislav Musicki, Marielle Berthier
  • Publication number: 20100143445
    Abstract: Depigmenting compositions having improved effectiveness in the dermatological or cosmetic treatment of pigmentation contain, in a physiologically acceptable medium, at least one compound selected from among rucinol and salts thereof, and at least one retinoid; such compositions are also useful in the prevention and/or dermatological treatment of skin hyperpigmentation, and also for the cosmetic treatment of photoinduced or chronological aging of the skin or of the skin appendages.
    Type: Application
    Filed: November 4, 2009
    Publication date: June 10, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Isabelle Pelisson, Itaru Suziki
  • Publication number: 20100124538
    Abstract: Topically applicable compositions useful for the depigmentation of the skin contain a fluocinolone acetonide depigmenting agent, at a concentration of from 0.0001% to 0.02% by weight, of the total weight of the composition, formulated into physiologically acceptable carrier therefor.
    Type: Application
    Filed: August 14, 2009
    Publication date: May 20, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Isabelle Pelisson, André Jomard
  • Publication number: 20100010049
    Abstract: Compounds corresponding to the following general formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine or else into cosmetic compositions; novel compounds of formula (II) are also thus useful:
    Type: Application
    Filed: January 12, 2009
    Publication date: January 14, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Itaru Suzuki, Irène Erdelmeier, Jean-Claude Yadan, Isabelle Pelisson
  • Publication number: 20090111783
    Abstract: Dermatological medicament compositions contain a combination of hydroquinone, fluocinolone acetonide and tretinoin and are useful for the treatment of the hyperpigmentation of pathological scars, namely, hypertrophic scars and keloidal scars.
    Type: Application
    Filed: October 24, 2008
    Publication date: April 30, 2009
    Applicant: GALDERMA S.A.
    Inventors: Isabelle PELISSON, Andre Jomard
  • Publication number: 20090018108
    Abstract: Hyperpigmentary skin disorders, notably those associated with psoriasis or eczema, are prevented/treated by administering to individuals in need of such treatment, thus effective amounts of medicaments containing a combination of fluocinolone acetonide, hydroquinone and tretinoin, formulated into a physiologically acceptable medium therefor.
    Type: Application
    Filed: June 11, 2008
    Publication date: January 15, 2009
    Applicant: GALDERMA S.A.
    Inventors: Isabelle Pelisson, Andre Jomard
  • Publication number: 20080219936
    Abstract: Depigmenting compositions for the skin, comprise, formulated into a physiologically acceptable medium, adapalene, at least one depigmenting agent and at least one anti-inflammatory agent, and to the pharmaceutical/cosmetic applications thereof.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 11, 2008
    Applicant: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Isabelle Pelisson, Andre Jomard
  • Publication number: 20080159969
    Abstract: The invention relates to a pharmaceutical or cosmetic composition comprising, in a physiologically acceptable medium, mequinol and at least one depigmenting agent, and to the use thereof.
    Type: Application
    Filed: May 13, 2005
    Publication date: July 3, 2008
    Applicant: Galderma Research & Development, S.N.C.
    Inventors: Isabelle Pelisson, Andre Jomard, Cecile Cousin
  • Publication number: 20050163731
    Abstract: Topically applicable skin depigmenting compositions, suited for treatment of such hyperpigmentary disorders as melasma and chloasma, contain a thus effective amount of at least one skin depigmenting active agent, for example hydroquinone or 4-hydroxyanisole, in admixture with a depigmentation-accelerating amount of adapalene (6-[3-(1-adamantyl)-4-methoxyphenyl]-2-napthanoic acid), and optionally with at least one sunscreen, formulated into a topically applicable, physiologically acceptable medium therefor.
    Type: Application
    Filed: January 26, 2005
    Publication date: July 28, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Isabelle Pelisson, Andre Jomard